Chlorhexidine as Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions

Sponsor

Federal University of Pelotas (Other)

Overall Status

Completed

CT.gov ID

NCT01947192

Collaborator

(none)

Enrollment

Location

Arms

Study Details

Study Description

Brief Summary

This study aims to evaluate the effect of chlorhexidine digluconate (CRX) application in etched dentin on the retention of noncarious cervical lesions restorations.

A randomized controlled split-mouth and blind trial will be carried out. Patients with at least two non-carious cervical lesions (NCL) will be selected. NCL will be randomly assigned according the type of teeth (incisors, canine or pre-molars) into two groups: control or experimental group (application of 2% CRX for 60 seconds after the acid etching procedure). Class V restorations will be performed out with an etch-and-rinse adhesive system (Adper Single Bond 2-3M ESPE) and a composite resin (Filtek Z350-3M ESPE) according the manufacture instructions, by previously trained operators. The restorations will be evaluated by a calibrate examiner at 1 week (baseline), and 6-month, 12-month and 24-month, using the World Dental Federation (FDI) criteria. The outcome is retention of the restoration.

Condition or Disease	Intervention/Treatment	Phase
Non-carious Cervical Lesions	Procedure: Treatment with chlorhexidine Procedure: Water pre-treatment	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

50 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Triple (Participant, Care Provider, Outcomes Assessor)

Primary Purpose:

Treatment

Official Title:

Chlorhexidine as Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions and Failure-prognostic Variables: A Randomized Controlled Trial

Study Start Date :

Nov 1, 2011

Actual Primary Completion Date :

Nov 1, 2012

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Chlorhexidine Dentin pre-treatment with a experimental solution (chlorhexidine), after the dentin acid etching	Procedure: Treatment with chlorhexidine Application of 2% chlorhexidine digluconate (60 seconds) after the etching procedure and before the adhesive system.
Placebo Comparator: Water Application of water (placebo) after dentin acid etching.	Procedure: Water pre-treatment Treatment of acid etched dentin with sterilized water for 60 s before adhesive system application

Arm

Intervention/Treatment

Experimental: Chlorhexidine

Dentin pre-treatment with a experimental solution (chlorhexidine), after the dentin acid etching

Procedure: Treatment with chlorhexidine

Application of 2% chlorhexidine digluconate (60 seconds) after the etching procedure and before the adhesive system.

Placebo Comparator: Water

Application of water (placebo) after dentin acid etching.

Procedure: Water pre-treatment

Treatment of acid etched dentin with sterilized water for 60 s before adhesive system application

Outcome Measures

Primary Outcome Measures

Change from baseline in Retention rates of the restoration at 24 months [6, 12 and 24 months]
Patients will be reevaluated at each specified time point and all restoration sites will be evaluated to check if the restoration will be still in place, or if it is missing, or if there is partial retention

Secondary Outcome Measures

Change from baseline in Post-operative sensitivity at 6-month [baseline and 6-month]
At each time-point, patients will be recalled and interviewed regarding any symptom related to each restorations placed.
Change from baseline in marginal staining rates at 6. 12 and 24 months [6, 12 and 24 months]
At each time-point, patients will be recalled and restorations will be reassessed in order to record changes in the rates of marginal staining, using the World Dental Federation (FDI) criteria for restorations assessment (Hickel et al 2010).

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 70 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Patients presenting at least two non-carious cervical lesions (NCL) in anterior, canine or pre-molars;
Patients who had more than 20 teeth in the mouth;
Patients who were at least 18 years of age at the time of treatment and capable to understand and sign the written informed consent;
NCL with at least 1 mm of depth in a vital permanent incisor, canine or premolar of the upper as the lower jaw.
NCL in the facial surface of the teeth with sometimes a small part extending interproximally;
Patients with good periodontal heath.

Exclusion Criteria:

Patients with smoking habits, practicing bruxism, severe systemic diseases, using active orthodontic treatment, malocclusion (Angle Class II or Class III);
Tooth with the NCL with the absent of antagonist;
NCL wear facets upper than 50% of the incisal/occlusion surface, as a result of tooth attrition;
Presence of caries or restorations in the area to be treated;
Full-mouth visible plaque index (VPI) or full-mouth gingival bleeding index upper than 20%, probing depth and clinical attachment loss values exceeding 4 mm with bleeding on probing;
Unwillingness to return for follow-ups or refuse to participate.